JOYN Advisors’s Gilead Sciences GILD Stock Holding History

JOYN Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$307K	Buy	4,109 +502	+14%	+$34.7K	0.1%	73
2019 Q4	$234K	Buy	3,607 +205	+6%	+$13.3K	0.05%	105
2019 Q3	$216K	Buy	3,402 +74	+2%	+$4.84K	0.05%	103
2019 Q2	$211K	Buy	+3,328	New	+$219K	0.05%	116
2019 Q1	–	Sell	-2,904	Closed	-$182K	–	607
2018 Q4	$182K	Sell	2,904 -780	-21%	-$54.5K	0.04%	117
2018 Q3	$284K	Sell	3,684 -173	-4%	-$13.1K	0.05%	106
2018 Q2	$273K	Sell	3,857 -1,337	-26%	-$94.4K	0.06%	108
2018 Q1	$392K	Sell	5,194 -5,040	-49%	-$401K	0.08%	80
2017 Q4	$733K	Buy	+10,234	New	+$777K	0.16%	54

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JOYN Advisors's GILD Position: Q1 2020 in Review

JOYN Advisors increased its Gilead Sciences (GILD) stake by 14% in Q1 2020, buying an estimated $34.7K and bringing the position to 4,109 shares worth $307K. The position accounts for 0.1% of the portfolio, ranked #73.

JOYN Advisors first reported a position in GILD in Q4 2017 and has held it in 9 quarters since. The position peaked at $733K in Q4 2017. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

JOYN Advisors held 4,109 shares of Gilead Sciences worth $307K as of Q1 2020.
JOYN Advisors bought 502 Gilead Sciences shares in Q1 2020, an estimated $34.7K.
Gilead Sciences made up 0.1% of JOYN Advisors's portfolio in Q1 2020, its #73 holding.
JOYN Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 9 quarters since.
JOYN Advisors's Gilead Sciences position peaked at $733K in Q4 2017.
1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on JOYN Advisors's 13F filing for Q1 2020, filed 30 Apr 2020.